In this study, the sensitivity of NSE was notably low, only 20.0% for the training set and 40.7% for the external set, potentially due to the predominance of early-stage cases and the inclusion of lung carcinoid tumor cases. This evidence concerns the gene ENO2 and lung carcinoid tumor.